Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pharmaceutical Companies

PUBLISHER: Grand View Research | PRODUCT CODE: 2017741

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2017741

Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Route Of Administration, By Molecule Type, By Drug Development, By Sales Channel, By Therapy Area, By Prescription, By Age Group, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Pharmaceutical Manufacturing Market Summary

The global pharmaceutical manufacturing market size was estimated at USD 616.15 billion in 2025 and is projected to reach USD 990.55 billion by 2033, growing at a CAGR of 5.88% from 2026 to 2033. The market is driven by demand for advanced therapeutics, biologics, and high-volume generic drugs alongside increasing chronic disease prevalence and healthcare spending.

Manufacturers are investing in automation, continuous manufacturing, and high-precision bioprocessing technologies to enhance efficiency, quality, and regulatory compliance. The market is growing as more people are affected by chronic diseases such as diabetes, cancer, and heart conditions. With more patients and advanced treatments, demand for both traditional drugs and complex biologics is rising. This has pushed manufacturers worldwide to scale up production capabilities while ensuring consistent quality, safety, and compliance with stringent regulatory frameworks. The increasing number of drug approvals by regulatory bodies is expected to drive growth in drug manufacturing processes. In 2025, the FDA approved 32 novel drugs, indicating a positive trend.

A major driver supporting the market is the rapid evolution of drug development technologies. Increasing adoption of biologics, biosimilars, cell and gene therapies, and personalized medicines is reshaping production requirements, prompting manufacturers to invest in flexible, high-precision bioprocessing systems. At the same time, the shift toward continuous manufacturing and automation is helping companies reduce operational costs, optimize output, and improve product reliability, all of which are essential for meeting the rising global demand.

Global Pharmaceutical Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical manufacturing market report based on molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and region:

  • Molecule Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Biologics & Biosimilars (Large Molecules)
    • Monoclonal Antibodies
    • Vaccines
    • Cell & Gene Therapy
    • Others
  • Conventional Drugs (Small Molecules)
  • Drug Development Outlook (Revenue, USD Billion, 2021 - 2033)
  • In-house
  • Outsource
  • Formulation Outlook (Revenue, USD Billion, 2021 - 2033)
  • Tablets
  • Capsules
  • Injectable
  • Sprays
  • Suspensions
  • Powders
  • Other Formulations
  • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
  • Oral
  • Topical
  • Parenteral
  • Inhalations
  • Other Routes of Administration
  • Therapy Area Outlook (Revenue, USD Billion, 2021 - 2033)
  • Cardiovascular Diseases (CVDs)
  • Pain
  • Diabetes
  • Cancer
  • Respiratory Diseases
  • Other Diseases
  • Prescription Outlook (Revenue, USD Billion, 2021 - 2033)
  • Prescription Medicines
  • Over-the-counter (OTC) Medicines
  • Age Group Outlook (Revenue, USD Billion, 2021 - 2033)
  • Children & Adolescents
  • Adults
  • Geriatric
  • Sales Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Retail
  • Non-retail
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68039-014-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Molecule Type
    • 1.2.2. Drug Development Type
    • 1.2.3. Formulation
    • 1.2.4. Routes of Administration
    • 1.2.5. Therapy Area
    • 1.2.6. Prescription
    • 1.2.7. Age Group
    • 1.2.8. Sales Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Pharmaceutical Manufacturing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Pharmaceutical Manufacturing Market: Molecule Type Business Analysis

  • 4.1. Molecule Type Market Share, 2025 & 2033
  • 4.2. Molecule Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Molecule Type, 2021 to 2033 (USD Billion)
  • 4.4. Biologics & Biosimilars (Large Molecules)
    • 4.4.1. Biologics & Biosimilars (Large Molecules) Market Estimates & Forecasts 2021 to 2033 (USD Billion)
      • 4.4.1.1. Monoclonal Antibodies
        • 4.4.1.1.1. Monoclonal Antibodies Market Estimates & Forecasts 2021 to 2033 (USD Billion)
      • 4.4.1.2. Vaccines
        • 4.4.1.2.1. Vaccines Market Estimates & Forecasts 2021 to 2033 (USD Billion)
      • 4.4.1.3. Cell & Gene Therapy
        • 4.4.1.3.1. Cell & Gene Therapy Market Estimates & Forecasts 2021 to 2033 (USD Billion)
      • 4.4.1.4. Others
        • 4.4.1.4.1. Others Market Estimates & Forecasts 2021 to 2033 (USD Billion)
  • 4.5. Conventional Drugs (Small Molecules)
    • 4.5.1. Conventional Drugs (Small Molecules) Market Estimates & Forecasts 2021 to 2033 (USD Billion)

Chapter 5. Pharmaceutical Manufacturing Market: Drug Development Business Analysis

  • 5.1. Drug Development Market Share, 2025 & 2033
  • 5.2. Drug Development Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Development, 2021 to 2033 (USD Billion)
  • 5.4. Outsource
    • 5.4.1. Outsource Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. In-house
    • 5.5.1. In-house Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Pharmaceutical Manufacturing Market: Formulation Business Analysis

  • 6.1. Formulation Market Share, 2025 & 2033
  • 6.2. Formulation Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2021 to 2033 (USD Billion)
  • 6.4. Tablets
    • 6.4.1. Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Capsules
    • 6.5.1. Capsules Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Injectable
    • 6.6.1. Injectable Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.7. Sprays
    • 6.7.1. Sprays Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.8. Suspensions
    • 6.8.1. Suspensions Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.9. Powders
    • 6.9.1. Powders Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.10. Other
    • 6.10.1. Other Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Pharmaceutical Manufacturing Market: Route of Administration Business Analysis

  • 7.1. Route of Administration Market Share, 2025 & 2033
  • 7.2. Route of Administration Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)
  • 7.4. Oral
    • 7.4.1. Oral Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Topical
    • 7.5.1. Topical Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 7.6. Parenteral
    • 7.6.1. Parenteral Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 7.7. Inhalations
    • 7.7.1. Inhalations Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 7.8. Other
    • 7.8.1. Other Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Pharmaceutical Manufacturing Market: Therapy Area Business Analysis

  • 8.1. Therapy Area Market Share, 2025 & 2033
  • 8.2. Therapy Area Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Therapy Area, 2021 to 2033 (USD Billion)
  • 8.4. Cardiovascular Diseases (CVDs)
    • 8.4.1. Cardiovascular Diseases (CVDs) Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.5. Pain
    • 8.5.1. Pain Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Diabetes
    • 8.6.1. Diabetes Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Cancer
    • 8.7.1. Cancer Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Respiratory Diseases
    • 8.8.1. Respiratory Diseases Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.9. Other
    • 8.9.1. Other Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Pharmaceutical Manufacturing Market: Prescription Business Analysis

  • 9.1. Prescription Market Share, 2025 & 2033
  • 9.2. Prescription Segment Dashboard
  • 9.3. Market Size & Forecasts and Trend Analysis, by Prescription, 2021 to 2033 (USD Billion)
  • 9.4. Prescription Medicine
    • 9.4.1. Prescription Medicine Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 9.5. Over-the-counter (OTC) Medicines
    • 9.5.1. Over-the-counter (OTC) Medicines Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 10. Pharmaceutical Manufacturing Market: Age Group Business Analysis

  • 10.1. Age Group Market Share, 2025 & 2033
  • 10.2. Age Group Segment Dashboard
  • 10.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2021 to 2033 (USD Billion)
  • 10.4. Children & Adolescents
    • 10.4.1. Children & Adolescents Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 10.5. Adult
    • 10.5.1. Adult Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 10.6. Geriatric
    • 10.6.1. Geriatric Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 11. Pharmaceutical Manufacturing Market: Sales Channel Business Analysis

  • 11.1. Sales Channel Market Share, 2025 & 2033
  • 11.2. Sales Channel Segment Dashboard
  • 11.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2021 to 2033 (USD Billion)
  • 11.4. Retail
    • 11.4.1. Retail Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 11.5. Non-Retail
    • 11.5.1. Non-Retail Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 12. Pharmaceutical Manufacturing Market: Regional Estimates & Trend Analysis

  • 12.1. Regional Market Share Analysis, 2025 & 2033
  • 12.2. Regional Market Dashboard
  • 12.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 12.4. North America
    • 12.4.1. North America Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.4.2. U.S.
      • 12.4.2.1. Key Country Dynamics
      • 12.4.2.2. Regulatory Framework
      • 12.4.2.3. U.S. Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.4.3. Canada
      • 12.4.3.1. Key Country Dynamics
      • 12.4.3.2. Regulatory Framework
      • 12.4.3.3. Canada Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.4.4. Mexico
      • 12.4.4.1. Key Country Dynamics
      • 12.4.4.2. Regulatory Framework
      • 12.4.4.3. Mexico Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 12.5. Europe
    • 12.5.1. Europe Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.2. UK
      • 12.5.2.1. Key Country Dynamics
      • 12.5.2.2. Regulatory Framework
      • 12.5.2.3. UK Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.3. Germany
      • 12.5.3.1. Key Country Dynamics
      • 12.5.3.2. Regulatory Framework
      • 12.5.3.3. Germany Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.4. France
      • 12.5.4.1. Key Country Dynamics
      • 12.5.4.2. Regulatory Framework
      • 12.5.4.3. France Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.5. Italy
      • 12.5.5.1. Key Country Dynamics
      • 12.5.5.2. Regulatory Framework
      • 12.5.5.3. Italy Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.6. Spain
      • 12.5.6.1. Key Country Dynamics
      • 12.5.6.2. Regulatory Framework
      • 12.5.6.3. Spain Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.7. Denmark
      • 12.5.7.1. Key Country Dynamics
      • 12.5.7.2. Regulatory Framework
      • 12.5.7.3. Denmark Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.8. Sweden
      • 12.5.8.1. Key Country Dynamics
      • 12.5.8.2. Regulatory Framework
      • 12.5.8.3. Sweden Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.5.9. Norway
      • 12.5.9.1. Key Country Dynamics
      • 12.5.9.2. Regulatory Framework
      • 12.5.9.3. Norway Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 12.6. Asia Pacific
    • 12.6.1. Asia Pacific Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.6.2. Japan
      • 12.6.2.1. Key Country Dynamics
      • 12.6.2.2. Regulatory Framework
      • 12.6.2.3. Japan Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.6.3. China
      • 12.6.3.1. Key Country Dynamics
      • 12.6.3.2. Regulatory Framework
      • 12.6.3.3. China Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.6.4. India
      • 12.6.4.1. Key Country Dynamics
      • 12.6.4.2. Regulatory Framework
      • 12.6.4.3. India Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.6.5. Australia
      • 12.6.5.1. Key Country Dynamics
      • 12.6.5.2. Regulatory Framework
      • 12.6.5.3. Australia Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.6.6. South Korea
      • 12.6.6.1. Key Country Dynamics
      • 12.6.6.2. Regulatory Framework
      • 12.6.6.3. South Korea Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.6.7. Thailand
      • 12.6.7.1. Key Country Dynamics
      • 12.6.7.2. Regulatory Framework
      • 12.6.7.3. Thailand Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 12.7. Latin America
    • 12.7.1. Latin America Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.7.2. Brazil
      • 12.7.2.1. Key Country Dynamics
      • 12.7.2.2. Regulatory Framework
      • 12.7.2.3. Japan Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.7.3. Argentina
      • 12.7.3.1. Key Country Dynamics
      • 12.7.3.2. Regulatory Framework
      • 12.7.3.3. China Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 12.8. Middle East and Africa
    • 12.8.1. Middle East and Africa Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.8.2. South Africa
      • 12.8.2.1. Key Country Dynamics
      • 12.8.2.2. Regulatory Framework
      • 12.8.2.3. South Africa Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.8.3. Saudi Arabia
      • 12.8.3.1. Key Country Dynamics
      • 12.8.3.2. Regulatory Framework
      • 12.8.3.3. Saudi Arabia Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.8.4. UAE
      • 12.8.4.1. Key Country Dynamics
      • 12.8.4.2. Regulatory Framework
      • 12.8.4.3. UAE Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 12.8.5. Kuwait
      • 12.8.5.1. Key Country Dynamics
      • 12.8.5.2. Regulatory Framework
      • 12.8.5.3. Kuwait Pharmaceutical Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 13. Competitive Landscape

  • 13.1. Participant Overview
  • 13.2. Company Market Position Analysis
  • 13.3. Company Categorization
  • 13.4. Strategy Mapping
  • 13.5. Company Profiles/Listing
    • 13.5.1. F. Hoffmann-La Roche Ltd.
      • 13.5.1.1. Company Overview
      • 13.5.1.2. Financial Performance
      • 13.5.1.3. Product Benchmarking
      • 13.5.1.4. Strategic Initiatives
    • 13.5.2. Novartis AG
      • 13.5.2.1. Company Overview
      • 13.5.2.2. Financial Performance
      • 13.5.2.3. Product Benchmarking
      • 13.5.2.4. Strategic Initiatives
    • 13.5.3. GSK plc
      • 13.5.3.1. Company Overview
      • 13.5.3.2. Financial Performance
      • 13.5.3.3. Product Benchmarking
      • 13.5.3.4. Strategic Initiatives
    • 13.5.4. Pfizer, Inc.
      • 13.5.4.1. Company Overview
      • 13.5.4.2. Financial Performance
      • 13.5.4.3. Product Benchmarking
      • 13.5.4.4. Strategic Initiatives
    • 13.5.5. Merck & Co., Inc.
      • 13.5.5.1. Company Overview
      • 13.5.5.2. Financial Performance
      • 13.5.5.3. Product Benchmarking
      • 13.5.5.4. Strategic Initiatives
    • 13.5.6. AstraZeneca
      • 13.5.6.1. Company Overview
      • 13.5.6.2. Financial Performance
      • 13.5.6.3. Product Benchmarking
      • 13.5.6.4. Strategic Initiatives
    • 13.5.7. Johnson & Johnson
      • 13.5.7.1. Company Overview
      • 13.5.7.2. Financial Performance
      • 13.5.7.3. Product Benchmarking
      • 13.5.7.4. Strategic Initiatives
    • 13.5.8. Sanofi SA
      • 13.5.8.1. Company Overview
      • 13.5.8.2. Financial Performance
      • 13.5.8.3. Product Benchmarking
      • 13.5.8.4. Strategic Initiatives
    • 13.5.9. Eli Lilly and Company
      • 13.5.9.1. Company Overview
      • 13.5.9.2. Financial Performance
      • 13.5.9.3. Product Benchmarking
      • 13.5.9.4. Strategic Initiatives
    • 13.5.10. AbbVie, Inc.
      • 13.5.10.1. Company Overview
      • 13.5.10.2. Financial Performance
      • 13.5.10.3. Product Benchmarking
      • 13.5.10.4. Strategic Initiatives
    • 13.5.11. Thermo Fisher Scientific, Inc.
      • 13.5.11.1. Company Overview
      • 13.5.11.2. Financial Performance
      • 13.5.11.3. Product Benchmarking
      • 13.5.11.4. Strategic Initiatives
    • 13.5.12. Wuxi Apptec
      • 13.5.12.1. Company Overview
      • 13.5.12.2. Financial Performance
      • 13.5.12.3. Product Benchmarking
      • 13.5.12.4. Strategic Initiatives
    • 13.5.13. Samsung Biologics
      • 13.5.13.1. Company Overview
      • 13.5.13.2. Financial Performance
      • 13.5.13.3. Product Benchmarking
      • 13.5.13.4. Strategic Initiatives
    • 13.5.14. FUJIFILM Biotechnologies
      • 13.5.14.1. Company Overview
      • 13.5.14.2. Financial Performance
      • 13.5.14.3. Product Benchmarking
      • 13.5.14.4. Strategic Initiatives
    • 13.5.15. Lonza
      • 13.5.15.1. Company Overview
      • 13.5.15.2. Financial Performance
      • 13.5.15.3. Product Benchmarking
      • 13.5.15.4. Strategic Initiatives
    • 13.5.16. Catalent, Inc.
      • 13.5.16.1. Company Overview
      • 13.5.16.2. Financial Performance
      • 13.5.16.3. Product Benchmarking
      • 13.5.16.4. Strategic Initiatives
    • 13.5.17. Jubilant Pharmova Limited
      • 13.5.17.1. Company Overview
      • 13.5.17.2. Financial Performance
      • 13.5.17.3. Product Benchmarking
      • 13.5.17.4. Strategic Initiatives
Show more
Product Code: GVR-4-68039-014-2

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List Of Abbreviation
  • Table 3. Global Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 4. Global Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 5. Global Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 6. Global Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 7. Global Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 8. Global Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 9. Global Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 10. Global Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 11. Global Pharmaceutical Manufacturing Market, By Region, 2021 - 2033 (USD Billion)
  • Table 12. North America Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 13. North America Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 14. North America Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 15. North America Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 16. North America Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 17. North America Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 18. North America Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 19. North America Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 20. U.S. Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 21. U.S. Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 22. U.S. Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 23. U.S. Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 24. U.S. Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 25. U.S. Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 26. U.S. Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 27. U.S. Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 28. Canada Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 29. Canada Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 30. Canada Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 31. Canada Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 32. Canada Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 33. Canada Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 34. Canada Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 35. Canada Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 36. Mexico Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 37. Mexico Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 38. Mexico Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 39. Mexico Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 40. Mexico Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 41. Mexico Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 42. Mexico Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 43. Mexico Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 44. Europe Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 45. Europe Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 46. Europe Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 47. Europe Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 48. Europe Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 49. Europe Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 50. Europe Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 51. Europe Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 52. UK Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 53. UK Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 54. UK Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 55. UK Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 56. UK Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 57. UK Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 58. UK Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 59. UK Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 60. Germany Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 61. Germany Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 62. Germany Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 63. Germany Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 64. Germany Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 65. Germany Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 66. Germany Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 67. Germany Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 68. France Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 69. France Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 70. France Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 71. France Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 72. France Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 73. France Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 74. France Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 75. France Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 76. Italy Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 77. Italy Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 78. Italy Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 79. Italy Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 80. Italy Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 81. Italy Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 82. Italy Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 83. Italy Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 84. Spain Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 85. Spain Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 86. Spain Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 87. Spain Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 88. Spain Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 89. Spain Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 90. Spain Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 91. Spain Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 92. Sweden Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 93. Sweden Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 94. Sweden Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 95. Sweden Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 96. Sweden Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 97. Sweden Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 98. Sweden Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 99. Sweden Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 100. Norway Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 101. Norway Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 102. Norway Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 103. Norway Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 104. Norway Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 105. Norway Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 106. Norway Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 107. Norway Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 108. Denmark Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 109. Denmark Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 110. Denmark Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 111. Denmark Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 112. Denmark Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 113. Denmark Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 114. Denmark Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 115. Denmark Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 116. Asia Pacific Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 117. Asia Pacific Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 118. Asia Pacific Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 119. Asia Pacific Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 120. Asia Pacific Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 121. Asia Pacific Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 122. Asia Pacific Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 123. Asia Pacific Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 124. China Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 125. China Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 126. China Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 127. China Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 128. China Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 129. China Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 130. China Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 131. China Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 132. Japan Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 133. Japan Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 134. Japan Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 135. Japan Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 136. Japan Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 137. Japan Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 138. Japan Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 139. Japan Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 140. India Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 141. India Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 142. India Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 143. India Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 144. India Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 145. India Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 146. India Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 147. India Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 148. Australia Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 149. Australia Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 150. Australia Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 151. Australia Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 152. Australia Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 153. Australia Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 154. Australia Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 155. Australia Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 156. Thailand Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 157. Thailand Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 158. Thailand Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 159. Thailand Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 160. Thailand Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 161. Thailand Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 162. Thailand Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 163. Thailand Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 164. South Korea Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 165. South Korea Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 166. South Korea Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 167. South Korea Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 168. South Korea Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 169. South Korea Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 170. South Korea Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 171. South Korea Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 172. Latin America Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 173. Latin America Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 174. Latin America Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 175. Latin America Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 176. Latin America Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 177. Latin America Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 178. Latin America Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 179. Latin America Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 180. Brazil Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 181. Brazil Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 182. Brazil Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 183. Brazil Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 184. Brazil Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 185. Brazil Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 186. Brazil Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 187. Brazil Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 188. Argentina Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 189. Argentina Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 190. Argentina Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 191. Argentina Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 192. Argentina Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 193. Argentina Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 194. Argentina Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 195. Argentina Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 196. Middle East and Africa Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 197. Middle East and Africa Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 198. Middle East and Africa Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 199. Middle East and Africa Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 200. Middle East and Africa Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 201. Middle East and Africa Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 202. Middle East and Africa Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 203. Middle East and Africa Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 204. Saudi Arabia Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 205. Saudi Arabia Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 206. Saudi Arabia Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 207. Saudi Arabia Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 208. Saudi Arabia Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 209. Saudi Arabia Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 210. Saudi Arabia Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 211. Saudi Arabia Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 212. South Africa Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 213. South Africa Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 214. South Africa Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 215. South Africa Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 216. South Africa Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 217. South Africa Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 218. South Africa Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 219. South Africa Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 220. UAE Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 221. UAE Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 222. UAE Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 223. UAE Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 224. UAE Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 225. UAE Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 226. UAE Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 227. UAE Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)
  • Table 228. Kuwait Pharmaceutical Manufacturing Market, By Molecule Type, 2021 - 2033 (USD Billion)
  • Table 229. Kuwait Pharmaceutical Manufacturing Market, By Drug Development Type, 2021 - 2033 (USD Billion)
  • Table 230. Kuwait Pharmaceutical Manufacturing Market, By Formulation, 2021 - 2033 (USD Billion)
  • Table 231. Kuwait Pharmaceutical Manufacturing Market, By Route Of Administration, 2021 - 2033 (USD Billion)
  • Table 232. Kuwait Pharmaceutical Manufacturing Market, By Therapy Area, 2021 - 2033 (USD Billion)
  • Table 233. Kuwait Pharmaceutical Manufacturing Market, By Prescription, 2021 - 2033 (USD Billion)
  • Table 234. Kuwait Pharmaceutical Manufacturing Market, By Age Group, 2021 - 2033 (USD Billion)
  • Table 235. Kuwait Pharmaceutical Manufacturing Market, By Sales Channel, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach (USD Billion)
  • Fig. 10 Competitive landscape
  • Fig. 11 Pharmaceutical Manufacturing Market dynamics
  • Fig. 12 Pharmaceutical Manufacturing Market: Porter's five forces analysis
  • Fig. 13 Pharmaceutical Manufacturing Market: PESTLE analysis
  • Fig. 14 Pharmaceutical Manufacturing Market: Molecule Type Movement Analysis
  • Fig. 15 Pharmaceutical Manufacturing Market: Molecule Type Outlook and Key Takeaways
  • Fig. 16 Biologics & Biosimilars (Large Molecules) Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 17 Monoclonal Antibodies Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 18 Vaccines Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 19 Cell & Gene Therapy Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 20 Others Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 21 Small Molecules Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 22 Pharmaceutical Manufacturing Market: Drug Development Type Movement Analysis
  • Fig. 23 Pharmaceutical Manufacturing Market: Drug Development Type Outlook and Key Takeaways
  • Fig. 24 Outsource Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 25 In-House Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 26 Pharmaceutical Manufacturing Market: Formulation Movement Analysis
  • Fig. 27 Pharmaceutical Manufacturing Market: Formulation Outlook and Key Takeaways
  • Fig. 28 Tablets Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 29 Capsules Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 30 Injectable Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 31 Sprays Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 32 Suspensions Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 33 Powders Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 34 Others Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 35 Pharmaceutical Manufacturing Market: Route of Administration Movement Analysis
  • Fig. 36 Pharmaceutical Manufacturing Market: Route of Administration Outlook and Key Takeaways
  • Fig. 37 Oral Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 38 Topical Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 39 Parenteral Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 40 Inhalation Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 41 Others Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 42 Pharmaceutical Manufacturing Market: Therapy Area Movement Analysis
  • Fig. 43 Pharmaceutical Manufacturing Market: Therapy Area Outlook and Key Takeaways
  • Fig. 44 CVDs Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 45 Pain Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 46 Diabetes Management Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 47 Cancer Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 48 Respiratory Diseases Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 49 Others Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 50 Pharmaceutical Manufacturing Market: Prescription Movement Analysis
  • Fig. 51 Pharmaceutical Manufacturing Market: Prescription Outlook and Key Takeaways
  • Fig. 52 Prescription Medicines Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 53 Over-The-Counter Medicines Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 54 Pharmaceutical Manufacturing Market: Age-Group Movement Analysis
  • Fig. 55 Pharmaceutical Manufacturing Market: Age-Group Outlook and Key Takeaways
  • Fig. 56 Children & Adolescents Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 57 Adults Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 58 Geriatric Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 59 Pharmaceutical Manufacturing Market: Sales Channel Movement Analysis
  • Fig. 60 Pharmaceutical Manufacturing Market: Sales Channel Outlook and Key Takeaways
  • Fig. 61 Retail Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 62 Non-Retail Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 63 Global Pharmaceutical Manufacturing Market: Regional Movement Analysis
  • Fig. 64 Global Pharmaceutical Manufacturing Market: Regional Outlook and Key Takeaways
  • Fig. 65 North America
  • Fig. 66 North America Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 67 U.S. Key Country Dynamics
  • Fig. 68 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 69 Canada Key Country Dynamics
  • Fig. 70 Canada Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 71 Mexico Key Country Dynamics
  • Fig. 72 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 73 Europe
  • Fig. 74 Europe Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 75 UK Key Country Dynamics
  • Fig. 76 UK Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 77 Germany Key Country Dynamics
  • Fig. 78 Germany Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 79 France Key Country Dynamics
  • Fig. 80 France Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 81 Italy Key Country Dynamics
  • Fig. 82 Italy Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 83 Spain Key Country Dynamics
  • Fig. 84 Spain Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 85 Sweden Key Country Dynamics
  • Fig. 86 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 87 Norway Key Country Dynamics
  • Fig. 88 Norway Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 89 Denmark Key Country Dynamics
  • Fig. 90 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 91 Asia Pacific Key Country Dynamics
  • Fig. 92 Asia Pacific Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 93 China Key Country Dynamics
  • Fig. 94 China Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 95 Japan Key Country Dynamics
  • Fig. 96 Japan Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 97 India Key Country Dynamics
  • Fig. 98 India Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 99 Australia Key Country Dynamics
  • Fig. 100 Australia Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 101 Thailand Key Country Dynamics
  • Fig. 102 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 103 South Korea Key Country Dynamics
  • Fig. 104 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 105 Latin America
  • Fig. 106 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 107 Brazil Key Country Dynamics
  • Fig. 108 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 109 Argentina Key Country Dynamics
  • Fig. 110 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 111 Middle East and Africa
  • Fig. 112 Middle East and Africa Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 113 Saudi Arabia Key Country Dynamics
  • Fig. 114 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 115 South Africa Key Country Dynamics
  • Fig. 116 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 117 UAE Key Country Dynamics
  • Fig. 118 UAE Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 119 Kuwait Key Country Dynamics
  • Fig. 120 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Billion)
  • Fig. 121 Participant Categorization
  • Fig. 122 Company market position analysis
  • Fig. 123 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!